جست‌وجوی استاد و پژوهشگر

Ann Marie Leenمشاهده پروفایل

استاد

• T cell immunotherapy
• Cancer immunotherapy
• Viral infections treatment
• +۴ مورد دیگر

Ann Marie Leen, Ph.D., is a Professor in the Department of Pediatrics-Hem-Onc and a Member of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. Her research focuses on T cell immunotherapy for viruses and cancer, particularly in the context of hematopoietic stem cell transplantation. She holds a PhD from the University of Birmingham (2002) and Baylor College of Medicine (2005). Education: PhD, University of Birmingham, United Kingdom (2002) PhD, Baylor College of Medicine, Houston, TX (2005) Research Interests: Dr. Leen’s work centers on cytotoxic T cell (CTL) therapies for viral infections and malignant diseases. Key areas include: Adoptive transfer of donor-derived virus-specific CTLs for adenoviral infections post-transplant Development of tumor-specific CTLs targeting cancer testis antigens (SSX2/SSX4) Immunotherapy protocols for relapsed EBV-negative Hodgkin’s disease and non-Hodgkin lymphoma Engineering T-cells with enhanced specificity and potency Her research combines clinical trials, translational studies, and preclinical models to advance T-cell-based therapies. Articles Overview: Recent work highlights advancements in CAR-T cell engineering, viral immunity, and tumor microenvironment modulation. Notable themes include: Optimizing CAR-T cell persistence and specificity Targeting viral antigens (EBV, Adenovirus) in immunocompromised patients Novel approaches to overcome tumor immune suppression Advising & Grants: Dr. Leen collaborates extensively on clinical trials and T-cell manufacturing protocols. While specific grant details are not listed, her work aligns with major initiatives in adoptive immunotherapy and cell therapy. Labs/Teams: Affiliated with the Center for Cell & Gene Therapy , a hub for pioneering cell-based therapies at Baylor College of Medicine.

Marc De Benedettiمشاهده پروفایل

استادیار

• Machine Learning
• Medical Data Analysis
• Geophysical Modeling
• +۳ مورد دیگر

Marc De Benedetti is an Assistant Professor, Teaching Stream in the Department of Computer Science at the University of Toronto's Mississauga campus within the Mathematical and Computational Sciences school. His work bridges computational methods with healthcare analytics, geophysical modeling, and educational innovation. He specializes in applying machine learning to medical datasets (e.g., SEER cancer data) for predictive modeling and has contributed to CAR T-cell therapy efficacy studies in oncology. His geoscience research focuses on spatial-temporal variability in climate systems, particularly in the Congo Basin and UK wind dynamics. De Benedetti also designs supplementary educational programs to support undergraduate STEM learners. His research emphasizes data-driven approaches to address challenges in healthcare, environmental science, and pedagogy. Research interests include: Machine learning applications in healthcare survival prediction Immunotherapy comparative efficacy analysis Spatial variability in climate and hydrology systems Wind energy potential modeling Innovative undergraduate physics/mathematics tutoring strategies His recent articles analyze treatment outcomes for blood cancers using CAR T-cell therapies, explore model resolution impacts on geophysical data accuracy, and develop predictive tools for cancer prognosis via SEER datasets. No scientific awards are explicitly mentioned in the provided materials. While no formal grants or student advisement records are listed, his work demonstrates strong engagement with both academic research and educational development initiatives. His research locations include the Congo Basin for hydroclimatic studies and the UK for wind energy modeling. Collaborations likely span medical institutions for oncology studies and climatological agencies for environmental data analysis.

• Adoptive Cell Therapy
• CAR T-cells
• Cancer Immunology
• +۹ مورد دیگر

Dr. Kavitha Gowrishankar is a Senior Lecturer in Immunology at the University of Sydney's School of Medical Sciences, under the Faculty of Medicine and Health. She is affiliated with the Westmead Institute for Medical Research, Kids Research (The Children's Hospital Westmead), and Sydney Cancer Partners. Her research focuses on adoptive cell therapy, CAR T-cells for cancers like leukemia, lymphoma, multiple myeloma, and pediatric solid tumors (sarcoma, brain cancer), as well as T cell receptor engineering and HIV viral reservoir eradication. She has pioneered the use of piggyBac transposase for T-cell genetic modification and investigated combination therapies targeting melanoma and other malignancies. Academic Background: PhD in Immunology (University of Sydney, 2005–2008) Research Training (Indian Institute of Science, India, 1992–1995) Master of Science in Bio-Medical Genetics (University of Madras, India, 1990–1992) Bachelor of Science in Botany (University of Madras, India, 1987–1990) Schooling in India (1975–1987) Research Interests: Her work bridges basic immunology and translational applications. She explores CAR T-cell engineering for pediatric and adult cancers, particularly targeting the tumor microenvironment and latent HIV reservoirs in CD4 T cells. Key innovations include optimizing transposon tools for CAR insertion and developing strategies to enhance CAR T-cell efficacy against solid tumors. She also investigates epigenetic regulators (e.g., BET/HDAC inhibitors) to combat melanoma resistance mechanisms. Articles Trends: Recent publications emphasize CAR T-cell safety (e.g., lymphoma risks), novel CAR designs (e.g., piggyBat transposase), and combination therapies targeting HIV reservoirs. Her work spans preclinical studies to clinical trials, with a focus on melanoma, myeloma, and pediatric sarcomas. She frequently collaborates on projects involving T-cell receptors and interferon modulation strategies. Awards: APA Scholarship (2005–2008) CSIR Research Fellowship (India, 1992–1995) Gold Medallist in M.Sc. (Bio-Medical Genetics, 1992) Gold Medallist in B.Sc. (Botany, 1990) Advising & Grants: Supervises PhD students in CAR T-cell applications for HIV and pediatric sarcomas. Leads grants including the E2CAR Trial (Phase I clinical trial for EphA2-targeted CAR T-cells in sarcoma), and collaborations targeting dual-specific CAR T-cells for HIV eradication. Her grants reflect a mix of preclinical and clinical translational research. Labs & Teams: Active in the Westmead Institute for Medical Research and Kids Research. Collaborates with the Sydney Cancer Partners consortium, focusing on novel cellular therapies and cross-disciplinary oncology solutions.

Alexander Bobikمشاهده پروفایل

استاد مدعو

• Vascular Biology
• Cardiovascular Disease
• Immunology
• +۳ مورد دیگر

Professor Alexander Bobik is an internationally recognized vascular biologist with 40 years of research experience in vascular biology and cardiovascular disease, particularly focusing on atherosclerosis. He holds the position of Adjunct Professor (Research) in Immunology at Monash University, affiliated with the Alfred Hospital Centre for Inflammatory Disease and Monash Health. His work has led to over 225 publications, including seminal studies on the role of immune cells (e.g., B cells, CD8 T cells) in atherosclerosis pathogenesis. He co-led a National Health and Medical Research Council-funded project (2011–2013) investigating B lymphocytes in atherosclerosis. Research interests include immunopathogenesis of atherosclerosis, hypertension, and the interplay between immune cells and vascular disease. Notable contributions include demonstrating proatherogenic roles of B2 cells and CD8 T cells, while B1a cells and regulatory T cells exhibit protective effects. His findings have redefined understanding of B cell contributions to atherosclerosis. Bobik serves on 12 editorial boards of biomedical journals, including Arteriosclerosis Thrombosis and Vascular Biology . He has supervised numerous postgraduate students and postdoctoral fellows globally. His research aligns with UN Sustainable Development Goals related to health and well-being. Key grants include the NHMRC-funded project on B lymphocytes in atherosclerosis. His work emphasizes translational research, identifying therapeutic targets like Factor XIIa inhibition and proteomic signatures for plaque stabilization. Collaborations span international institutions, focusing on immune mechanisms in cardiovascular diseases.

Pouya Faridiمشاهده پروفایل

پژوهشگر ارشد

• Proteomics
• Cancer Immunotherapy
• Mass Spectrometry
• +۳ مورد دیگر

Dr. Pouya Faridi is a Senior Research Fellow at Monash University's School of Clinical Sciences and heads the Translational Antigen Discovery Laboratory. He holds a pharmacy doctorate and PhD from Shiraz University of Medical Sciences, Iran, followed by postdoctoral research at ETH Zurich and Monash University. His research focuses on developing mass-spectrometry and proteomics technologies for identifying cancer immunotherapy targets, with clinical applications in cancer vaccines. He co-directs the Monash Clinical Proteomics Facility and leads projects funded by NHMRC, Cancer Australia, and the Victorian Cancer Agency. **Education**: PharmD, Shiraz University of Medical Sciences, Iran PhD, Shiraz University of Medical Sciences, Iran **Research Interests**: Biomarker discovery via mass spectrometry Immunopeptidome analysis for precision oncology Development of novel cancer vaccines Proteomics-based theranostics **Awards & Grants**: Victorian Cancer Agency mid-career fellowship (2021) Australian Melanoma Research Foundation Early Career Award (2021) Lead investigator on NHMRC grants targeting tumor antigens Supported by Isabella & Marcus Foundation for pediatric brain tumor research **Labs & Teams**: Translational Antigen Discovery Laboratory (Monash) Co-director of Monash Clinical Proteomics Facility Collaborations with Hudson Institute of Medical Research

Kim Jacobsonمشاهده پروفایل

استاد

• Immunology
• B cell memory
• Epigenomics
• +۳ مورد دیگر

Professor Kim Jacobson is a Professor (Research) in the Department of Biochemistry and Molecular Biology at Monash University , Australia, and leads the B cells, Antibody, Memory Laboratory within the Monash Biomedicine Discovery Institute . She is a NHMRC Investigator Fellow and Bellberry-Viertel Senior Medical Research Fellow , recognized for her groundbreaking work in immunology and epigenetics. Education: PhD, Centenary Institute and Garvan Institute of Medical Research (2007) Postdoctoral training, Yale University (NHMRC CJ Martin Fellowship) Research Interests: Professor Jacobson's research focuses on understanding the molecular and epigenetic mechanisms underlying the formation of immune memory. Her lab investigates how chromatin modifications and transcriptional programs regulate B cell differentiation, memory formation, and antibody responses, particularly in the context of chronic infectious diseases and vaccine development. Scientific Awards: Victorian Young Tall Poppy Science Award (2016) Monash University Vice-Chancellor’s Diversity and Inclusion Award (2017) Advising & Grants: She currently supervises several PhD students and has received substantial funding from the NHMRC, ARC, MRFF, Cancer Institute NSW, and Leukaemia Foundation of Australia. Her projects span from epigenetic regulation of humoral immunity to AI-driven identification of post-acute sequelae of SARS-CoV-2 (PASC). Laboratory & Team: The Jacobson Lab is part of the Immunity Program at Monash Biomedicine Discovery Institute. The team includes postdoctoral researchers and graduate students working collaboratively on cutting-edge immunological research using advanced techniques like single-cell RNA-seq, ATAC-seq, and CRISPR-based epigenome editing.

Matthieu Defranceمشاهده پروفایل

دانشیار

• Gene Regulation
• Epigenetics
• Epigenomics
• +۶ مورد دیگر

Matthieu Defrance is an Associate Professor in the Computer Science Department at Université Libre de Bruxelles (ULB), Belgium, a position he has held since October 2016. Prior to this, he worked as a PostDoc at ULB's Laboratory of Cancer Epigenetics from May 2010 to September 2016. Dr. Defrance's research bridges computer science with biological sciences, focusing on computational methods for analyzing complex biological data. His work spans epigenetics, genomics, and algorithm development for biological applications. His primary research interests include: Gene Regulation and Chromatin Biology Epigenetics and Epigenomics DNA Methylation analysis Computational Statistics for biological data Algorithm Development for genomic applications Next Generation Sequencing data analysis Dr. Defrance's publication record demonstrates a strong interdisciplinary approach, with recent work focusing on improving DNA methylation analysis techniques, developing novel bioinformatics tools like RedRibbon for gene expression signature comparison, and applying these methods to understand diseases like diabetes and cancer. His research shows consistent innovation in computational biology, with publications spanning from method development to biological applications across diverse fields including diabetes genetics, cancer epigenetics, and evolutionary adaptations in desert ants. With 61 publications and nearly 5,000 citations, Dr. Defrance has established himself as a significant contributor to computational biology and epigenetics research.

Ola Hermansonمشاهده پروفایل

استاد

• Neurodevelopment
• Neuro-oncology
• Epigenetics
• +۵ مورد دیگر

Ola Hermanson is a Professor of Neuroscience at the Department of Neuroscience, Karolinska Institutet. His research focuses on understanding transcriptional and epigenetic mechanisms governing brain development, function, and disease, including neurodevelopmental disorders and brain tumors like glioblastoma. He employs cutting-edge technologies such as 3D bioprinting, bioelectronics, and molecular biology to study neural stem cells and cancer stem cells. Education and Positions: Professor of Neuroscience, Karolinska Institutet (2021–present) Senior Scientist, Karolinska Institutet (2009–2021) Assistant Professor, Karolinska Institutet (2003–2009) Postdoctoral Training, UC San Diego (1997–2002) PhD in System Neurobiology, Linköping University (1991–1997) Medical School, Lund University (1987–1990) Research Interests: Neural stem cell differentiation, epigenetic regulation, glioblastoma and medulloblastoma biology, biomedical engineering, and biomaterials. His lab develops technologies like 3D printing and bioelectronics to advance precision medicine. Publications: Over 70 peer-reviewed articles in prestigious journals like Nature , Cell , and Molecular Psychiatry . Recent work includes lithium's role in reversing radiation damage in neural progenitors and bioprinting for tumor modeling. Awards: Includes the ENI Young Investigator Award (2005), Strategic Professorship (2021), and recognition from the Canadian Government for Sweden-Canada collaboration. Teaching and Outreach: Course coordinator for neuroscience education programs (FoLäk1/2, anatomy courses). Engaged in pedagogical innovation, including TBL-based learning and neurotech education through NeurotechEU. Labs/Teams: Leads the Molecular Neurodevelopment and Neuro-Oncology group at KI. Founded the imaging core facility CLICK and co-founded Celluminova (stem cell markers SME).

• Respiratory Medicine
• Pulmonary Fibrosis
• Chronic Obstructive Pulmonary Disease (COPD)
• +۳ مورد دیگر

Magnus Sköld is a Professor/Senior Physician at Karolinska Institutet, leading the Idiopathic Pulmonary Fibrosis (IPF) Research Group within the Department of Medicine, Solna. His primary affiliation is with Karolinska Institutet, a renowned medical university. He has held his professorship since 2007 and previously served as Director of Studies at KI from 2005 to 2017. Sköld's research focuses on chronic respiratory disorders, including Chronic Obstructive Pulmonary Disease (COPD) , pulmonary fibrosis , and autoimmune/inflammatory mechanisms . His group explores these conditions through clinical studies, patient cohort analyses, and translational approaches combining immunohistochemistry, omics technologies, and molecular biology. Key projects include: Establishing a national IPF registry and biobank in Sweden, Investigating COPD in never-smokers using the SCAPIS cohort, Linking upper and lower airway pathologies, Studying post-COVID-19 lung outcomes using AI-driven imaging. His work is funded by grants from the Swedish Heart-Lung Foundation, ALF Medicine, and industry collaborations (e.g., Boehringer Ingelheim). He advises PhD students like Lisa Carlson (2021) and mentors researchers in inflammation, pulmonary fibrosis, and COPD mechanisms. Sköld's research also addresses translational challenges, such as developing biomarkers and therapeutic targets for IPF. He collaborates with international teams on projects like the SCAPIS study and imaging-based AI applications for diagnostics.

Ayse Latifمشاهده پروفایل

مدرس

• Cancer Biology
• Medical Imaging
• Pharmaceutical Sciences
• +۳ مورد دیگر

Ayse Latif is a Lecturer in Pharmaceutical Biology at the School of Pharmacy. Her research focuses on cancer biology, medical imaging, and pharmaceutical sciences, contributing to advancements in oncology and biomedical engineering. She has published extensively on topics such as tumor microenvironment dynamics, metastasis mechanisms, and therapeutic tracking via imaging technologies. Research Interests: Cancer Biology: Investigating mechanisms of tumor progression and metastasis in breast, endometrial, and pancreatic cancers. Medical Imaging: Developing oxygen-enhanced MRI techniques to monitor hypoxia modification and drug efficacy in cancer therapy. Pharmaceutical Sciences: Exploring drug mechanisms and therapeutic strategies for lymphoma and CAR T-cell treatments. Key Contributions: Her work bridges biomedical engineering and oncology, emphasizing the role of matrix stiffness in cancer cell behavior and the prognostic value of biomarkers like MCT1 in endometrial cancer. Advising & Grants: Latif has supervised 4 research works but no student names are listed. Her research collaborations span institutions globally, focusing on cancer imaging, metastasis, and therapeutic efficacy studies.

T. Thang Vo-Doanمشاهده پروفایل

مدرس

• Biorobotics
• Cyborg Insects
• Bio-inspired Robotics
• +۱۳ مورد دیگر

Dr T. Thang Vo-Doan is a Lecturer at the University of Queensland in the School of Mechanical & Mining Engineering . He directs the UQ Biorobotics Lab and serves as an affiliate of both the Future Autonomous Systems and Technologies and the Queensland Brain Institute . PhD in Mechanical Engineering, Nanyang Technological University (2016) M.Eng. in Manufacturing Engineering, Ho Chi Minh City University of Technology (2010) B.Eng. in Mechanical Engineering, Ho Chi Minh City University of Technology (2008) His research focuses on biohybrid robotics , integrating biological systems with technology through cyborg insects , bio-inspired robotics , and fast lock-on tracking systems. He explores insect biomechanics and brain imaging in untethered insects , developing platforms for search-and-rescue missions and environmental monitoring. Recent work trends include: 2025: On-demand climbing control for cyborg beetles 2024: High-resolution insect tracking and soft textile muscles 2023: Intelligent insect–computer hybrid robots 2022: Autonomous navigation and robotic leg design 2018: Ultralightweight living robots Scientific honors: Human Frontier Science Program Cross-disciplinary Fellowship (2019-2022) He supervises projects on: Insect-machine hybrid robots Insect-inspired robotics Fast lock-on tracking Insect locomotion biomechanics Current grants include: NHMRC IDEAS Grant (2025-2028): Infrared and AI for Ross River virus surveillance Queensland Corrective Services Grant (2024-2027): Wastewater drug misuse analysis

Dan Yuanمشاهده پروفایل

مدرس

• Microfluidics
• Biomedical Engineering
• Environmental Applications
• +۳ مورد دیگر

Dr. Dan Yuan is a Lecturer in Mechanical and Biomedical Engineering and an ARC DECRA Fellow at the University of Queensland's School of Mechanical and Mining Engineering. She holds affiliations with the Centre for Advanced Materials Processing and Manufacturing (AMPAM) and the Faculty of Engineering, Architecture, and Information Technology. Her research focuses on viscoelastic microfluidics, with applications in biomedical and environmental fields. She has secured over $1.6M in competitive grants, including ARC DECRA, JSPS, and Alfred Deakin Fellowships. Dr. Yuan completed her PhD at the University of Wollongong (2018), followed by postdoctoral roles at the University of Tokyo and Deakin University. She has published over 70 peer-reviewed articles in journals like Nat. Commun. , Lab Chip , and Small , with an h-index of 30. Her work emphasizes particle/cell manipulation, microalgae detection, and smart sensors. Research Interests: Interdisciplinary research in microfluidics, microfabrication, and viscoelastic fluid dynamics. Her innovations include shape-based cell sorting and point-of-need diagnostic devices. Notable achievements include cover articles in Lab Chip and media recognition for breakthroughs in blood plasma extraction and cyanobacteria separation. Grants & Awards: ARC DECRA Fellowship (2024–2027), JSPS Fellowship, Alfred Deakin Fellowship, and multiple scholarships. She reviews for ACS Nano , Lab on a Chip , and others, and co-edits journals like Biosensors . Advising: Supervises PhD projects on viscoelastic fluid physics and microfluidic platforms. Available for candidates in engineering, IT, physics, and biomedicine. Current focus includes non-Newtonian fluid dynamics and environmental monitoring. Labs/Teams: Leads research in AMPAM and collaborates with global institutions. Her lab develops cutting-edge microfluidic technologies and smart sensors for biomedical and environmental challenges.

Yaoying Wuمشاهده پروفایل

استادیار

• Synthetic Biomaterials
• Peptide Assembly
• Vaccine Design
• +۳ مورد دیگر

Yaoying Wu is an Assistant Professor in the Department of Biomedical & Chemical Engineering at Syracuse University, affiliated with the Bioinspired Institute. Her research focuses on engineering biomaterials to regulate immune functions for therapeutic applications, particularly in cancer immunotherapy and vaccine design. She holds a Ph.D. from the University of Minnesota, an M.S. from Beijing University of Chemical Technology, and a B.E. from Tianjin University. Postdoctoral training included Duke University and the University of Chicago. Research interests include synthetic biomaterials, peptide assembly, immunoengineering, and vaccine development. Her work integrates biomaterial platforms to modulate immune responses via controlled delivery of molecular stimuli. Notable contributions include supramolecular peptide nanofiber vaccine platforms and AAV-CRISPR genome editing studies. Awards: Duke Incubation Fund (Co-PI, 2019), American Chemical Society Excellence in Graduate Polymer Research Award (2014) Labs/Teams: Leads the Wu Lab at Syracuse University, part of the Bioinspired Institute Her research missions include harnessing immunity for therapeutics, advancing immunobiology understanding, and fostering inclusive education in biomedical engineering. Current projects emphasize orchestrating cellular dynamics for immune modulation and localized immune responses for disease treatment.

Owen A. O'Connorمشاهده پروفایل

استاد بالینی

• Lymphoma
• T-Cell Lymphoma
• Drug Development
• +۳ مورد دیگر

Dr. Owen A. O'Connor is an internationally renowned Clinical Professor of Medicine and Pharmacology at Columbia University's Vagelos College of Physicians and Surgeons, with over 25 years of experience in academic medicine. He currently serves as Director of the Program for T-Cell Lymphoma Research at the E. Couric Cancer Center, University of Virginia Cancer Center, and as Professor in the Department of Microbiology, Immunology, and Cancer Biology at the University of Virginia. University of Medicine and Dentistry of New Jersey (MD, PhD) Internship/Residency in Internal Medicine, Weill Cornell University Medical Center Fellowships in Medical Oncology (Memorial Sloan Kettering Cancer Center) and Clinical Pharmacology (Weill Cornell) Dr. O'Connor's research focuses on lymphoma diagnosis and treatment, particularly T-cell lymphoma. He has pioneered first-in-class drugs, including a global therapeutic co-invention for T-cell lymphoma, and contributes to precision cancer therapy advancements through editorial leadership. Scientific Advisory Board, Lymphoma Research Foundation Scientific Advisory Board, Leukemia Lymphoma Society Peer-reviewed publications: Over 200 articles, first textbook on Peripheral T-Cell Lymphoma Scientific Awards: American Cancer Society Research Professorship Top 50 Irish-Americans in Science and Medicine New Jersey Inventors Hall of Fame inductee

Hisham M. Abdel-Azimمشاهده پروفایل

استاد

• Pediatric Hematology/Oncology
• Hematopoietic Cell Transplantation
• Cellular Therapy
• +۵ مورد دیگر

Hisham M. Abdel-Azim, MD, MS is a Professor at the School of Medicine with appointments in three divisions: Pediatrics (Hematology/Oncology Division), Medicine, and Basic Sciences (Biochemistry Division) at New York Medical College. His work focuses on pediatric hematopoietic cell transplantation, leukemia research, and cellular therapy development. Dr. Abdel-Azim's research interests span multiple areas of pediatric hematology and oncology: Pediatric Hematopoietic Cell Transplantation and Cellular Therapy Leukemia Biology and Treatment Strategies Stem Cell Transplantation Complications and Management Novel Immunotherapies for Pediatric Cancers Genomic and Molecular Mechanisms in Hematologic Malignancies Transplant-Related Toxicities and Late Effects His recent publications (2024-2025) demonstrate a strong focus on improving outcomes in pediatric hematopoietic cell transplantation, with particular emphasis on managing complications like veno-occlusive disease, optimizing conditioning regimens, and developing novel cellular therapies. His work spans from basic science investigations of molecular mechanisms in leukemia to large multi-center clinical trials through the Children's Oncology Group and other consortia. A significant portion of his research addresses the unique challenges of treating pediatric patients with hematologic malignancies, with publications covering acute lymphoblastic leukemia, acute myeloid leukemia, and severe combined immunodeficiency. Dr. Abdel-Azim serves as Principal Investigator for numerous research projects funded by prestigious organizations including the National Cancer Institute, Children's Oncology Group, National Marrow Donor Program, and industry partners. His work often involves multi-center collaborations across the United States and internationally. He serves as a key investigator in multiple clinical trials focused on: Novel cellular therapies for relapsed/refractory leukemias Optimizing conditioning regimens for hematopoietic cell transplantation Understanding and preventing transplant complications Genomic mechanisms of treatment resistance International registry studies for cellular therapy outcomes